Cypherpunk Technologies Inc. CYPH
Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026
Cypherpunk Technologies Inc. (CYPH) is a healthcare company listed in the US with a market value of about $202M.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is value (2/5); the weakest is future growth (0/5).
Key numbers: a P/E of 3.0, a 5-year average ROIC of -81%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 100% below the current price.
About Cypherpunk Technologies
Cypherpunk Technologies is listed in the US and classified in biotechnology: pharmaceutical preparations. It was profitable in 1 of the last 10 years in our data. Its share count rose by 524% over three years (dilution for shareholders).
Score: 0.8 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $2M | $2M | — | — | — | — |
| Net income | $5M | -$68M | -$81M | -$55M | -$41M | -$28M | -$33M | -$23M | -$30M | -$26M |
| Free cash flow | — | — | — | — | — | — | -$27M | — | -$22M | -$25M |
| EPS (diluted) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-4.70 | $-6.30 | $-14.70 | $-21.10 | $-33.10 | — |
| Net margin | — | — | — | — | -2705.8% | -1834.3% | — | — | — | — |
| ROIC | -21.1% | -156.7% | -113.8% | -75.3% | -38.2% | -60.5% | — | -222.3% | -289.5% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 1 analysts is $4.90, 162% above the current price; targets range from $4.90 to $4.90; the consensus rating is “none”; expected EPS is $-0.04 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Cypherpunk Technologies’s P/E ratio?
About 3.0, based on the last twelve months of diluted earnings per share (forward P/E about 3.7).
Is Cypherpunk Technologies stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 100% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Cypherpunk Technologies pay a dividend?
Not currently.
Is Cypherpunk Technologies a good stock to buy?
We do not give buy or sell advice. Cypherpunk Technologies scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.